1. Home
  2. VRTX vs NKE Comparison

VRTX vs NKE Comparison

Compare VRTX & NKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
  • NKE
  • Stock Information
  • Founded
  • VRTX 1989
  • NKE 1964
  • Country
  • VRTX United States
  • NKE United States
  • Employees
  • VRTX N/A
  • NKE N/A
  • Industry
  • VRTX EDP Services
  • NKE Shoe Manufacturing
  • Sector
  • VRTX Technology
  • NKE Consumer Discretionary
  • Exchange
  • VRTX Nasdaq
  • NKE Nasdaq
  • Market Cap
  • VRTX 104.8B
  • NKE 106.1B
  • IPO Year
  • VRTX 1991
  • NKE 1980
  • Fundamental
  • Price
  • VRTX $484.24
  • NKE $76.51
  • Analyst Decision
  • VRTX Buy
  • NKE Buy
  • Analyst Count
  • VRTX 25
  • NKE 32
  • Target Price
  • VRTX $505.61
  • NKE $91.30
  • AVG Volume (30 Days)
  • VRTX 1.5M
  • NKE 13.3M
  • Earning Date
  • VRTX 02-10-2025
  • NKE 03-20-2025
  • Dividend Yield
  • VRTX N/A
  • NKE 2.09%
  • EPS Growth
  • VRTX N/A
  • NKE N/A
  • EPS
  • VRTX N/A
  • NKE 3.24
  • Revenue
  • VRTX $11,020,100,000.00
  • NKE $48,978,000,000.00
  • Revenue This Year
  • VRTX $9.62
  • NKE N/A
  • Revenue Next Year
  • VRTX $9.25
  • NKE $1.83
  • P/E Ratio
  • VRTX N/A
  • NKE $23.60
  • Revenue Growth
  • VRTX 11.66
  • NKE N/A
  • 52 Week Low
  • VRTX $377.85
  • NKE $68.62
  • 52 Week High
  • VRTX $519.88
  • NKE $106.62
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 65.58
  • NKE 56.08
  • Support Level
  • VRTX $451.99
  • NKE $70.33
  • Resistance Level
  • VRTX $469.55
  • NKE $73.60
  • Average True Range (ATR)
  • VRTX 11.70
  • NKE 2.17
  • MACD
  • VRTX 0.97
  • NKE 0.50
  • Stochastic Oscillator
  • VRTX 83.48
  • NKE 82.65

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About NKE Nike Inc.

Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.

Share on Social Networks: